Sellas Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on developing novel therapeutics for a broad range of cancer indications. It serves patients with hematologic malignancies and solid tumors through its product candidates, including galinpepimut-S (GPS) and SLS009.
Some research tools need a free Smallfolk account or a Smallfolk Pro plan.